Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  05/16 04:00:01 pm EDT
243.87 USD   +0.19%
05/16AMGEN INC. : Ex-dividend day for
FA
05/13Avantor Names Jonathan Peacock Chairman
MT
05/12Amgen and lance bass partner to encourage people to do a 'double take' to recognize the early signs of psoriatic arthritis
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Amgen Secures Japanese Approval of Non-Small Cell Lung Cancer Drug Lumakras

01/20/2022 | 05:09am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMGEN INC. 0.19% 243.87 Delayed Quote.8.40%
EURO / DIRHAM (EUR/AED) 0.71% 3.86 Delayed Quote.-8.50%
ON SEMICONDUCTOR CORPORATION -1.83% 55.15 Delayed Quote.-18.80%
US DOLLAR / DIRHAM (USD/AED) 0.00% 3.67265 Delayed Quote.0.01%
All news about AMGEN INC.
05/16AMGEN INC. : Ex-dividend day for
FA
05/13Avantor Names Jonathan Peacock Chairman
MT
05/12Amgen and lance bass partner to encourage people to do a 'double take' to recognize the..
PR
05/12BridgeBio Inks BBP-398 License With Bristol Myers
DJ
05/11TRANSCRIPT : Amgen Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-202..
CI
05/11INSIDER SELL : Amgen
MT
05/10Pfizer to pay $11.6 bln for Biohaven to tap migraine market
RE
05/10Mizuho Securities Lifts Amgen's Price Target to $208 From $202, Citing Repatha Peak Rev..
MT
05/09Amgen announces webcast of 2022 bank of america healthcare conference
AQ
05/06Amgen announces webcast of 2022 bank of america healthcare conference
PR
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Financials (USD)
Sales 2022 26 205 M - -
Net income 2022 6 905 M - -
Net Debt 2022 27 209 M - -
P/E ratio 2022 19,2x
Yield 2022 3,11%
Capitalization 130 B 130 B -
EV / Sales 2022 6,01x
EV / Sales 2023 5,67x
Nbr of Employees 24 200
Free-Float 99,8%
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Last Close Price 243,87 $
Average target price 246,46 $
Spread / Average Target 1,06%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Senior VP-Translational Sciences & Oncology
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.8.40%130 275
JOHNSON & JOHNSON4.10%468 600
PFIZER, INC.-14.19%284 304
ABBVIE INC.14.82%274 733
ELI LILLY AND COMPANY8.38%269 490
ROCHE HOLDING AG-14.96%260 807